Researchers identify new mechanism to target ‘undruggable’ cancer gene
(NEW YORK, NY, April 18, 2016) — RAS genes are mutated in more than 30 percent of human cancers and represent one of the most...
NEWS INDEX
Young adult survivors of childhood cancer report feeling middle-aged
BOSTON (April 21, 2016) – Do survivors of childhood cancer return to normal health as they grow up? According to new research from Dana-Farber/Boston Children's...
No risk association observed for anthracycline chemotherapy, cognitive decline
New data analyses found no association between anthracycline chemotherapy and greater risk of cognitive decline in breast cancer survivors, according to an article published online...
No increased risk of fatal CV events for breast cancer patients on newer hormone therapy
PASADENA, Calif., April 21, 2016 –In a new study from Kaiser Permanente, researchers found the use of aromatase inhibitors, hormone-therapy drugs used to treat patients...
Wellderly study suggests link between cognitive decline genes and healthy aging
LA JOLLA, Calif. – An eight-year-long accrual and analysis of the whole genome sequences of healthy elderly people, or "Wellderly," has revealed a higher-than-normal presence...
Study finds explanation for some treatment-resistant breast cancers
A targeted therapy for triple-negative breast cancer (TNBC), the most aggressive form of breast cancer, has shown potential promise in a recently published study. TNBC...
Study reveals a basis for attention deficits
More than 3 million Americans suffer from attention deficit hyperactivity disorder (ADHD), a condition that usually emerges in childhood and can lead to difficulties at...
POPULAR NEWS
-
Insilico Medicine receives IND approval from FDA for novel MAT2A inhibitor ISM3412
-
San Antonio-based SwRI to construct first facility outside of Texas
-
Aston University to help Saudi Arabia turn waste into energy
-
Professor Miguel Ángel García receives the prestigious ERC Advanced Grant from the European Research Council